Panacea Biotec P/E Ratio
Panacea Biotec (PANACEABIO) P/E ratio is not applicable — EPS (TTM) ₹-0.88. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company reported a loss in the most recent quarter. P/E ratio is not meaningful for loss-making periods.
Current EPS: ₹-0.88
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Mar 2026 | 0.08 | -1 | Profit |
| Sept 2025 | -2.27 | -14 | Loss |
| Mar 2025 | -0.31 | -2 | Loss |
| Jun 2025 | 0.66 | 4 | Profit |
| Dec 2025 | 0.65 | 4 | Profit |
| Sept 2024 | 0.77 | 5 | Profit |
| Mar 2024 | -0.23 | -2 | Loss |
| Jun 2024 | -2.59 | -16 | Loss |
Healthcare Peers with Valid P/E Ratios — PANACEABIO Comparison
Healthcare sector average P/E 54.8, median 31.04 — PANACEABIO excluded (negative EPS).
Sector Average PE
54.8
Sector Median PE
31.04
Lowest PE
2.86
Profitable Companies
195
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Sunrest Lifescience | SUNREST | 3.65 | ₹29 | Low |
| Phaarmasia | PHRMASI | 3.89 | ₹69 | Low |
| JFL Life Sciences | JFLLIFE | 4.64 | ₹59 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.69 | ₹7,502 | Low |
| Shelter Pharma | SHELTER | 5.32 | ₹50 | Low |
| Mono Pharmacare | MONOPHARMA | 6.02 | ₹19 | Low |
| Royal Sense | ROYAL | 7.4 | ₹51 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹79 | Low |
| Amwill Health Care | AMWILL | 7.71 | ₹88 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see PANACEABIO share price.
- Read Panacea Biotec dividend payments for the complete payout history and dividend yield track record.
- See Panacea Biotec P/B ratio trends to compare market price against book value per share.